The complex terminology “Substandard/spurious/falsely-labelled/ falsified/counterfeit” (SSFFC) medical products was proposed 6 years ago by the Director General as a provisional term. Disappointedly, as time has passed, the only one element that changed is the temporary use of the terminology.
Why are these terms concerning? Because they conflate the issue of the quality of medicines with asserted breaches of intellectual property rights.